Skip to content
GK24
NationalMedium

What is the estimated annual saving to consumers from the revised anti-cancer drug prices?

  1. A.Rs 1,250 crore
  2. B.Rs 2,340 crore
  3. C.Rs 3,502.31 crore
  4. D.Rs 7,800 crore

Correct answer

C. Rs 3,502.31 crore

Explanation

The correct answer is Rs 3,502.31 crore, the yearly saving the government expects buyers to make once the revised rates begin on 9 November 2026. The figure follows from price cuts reported in 1031 anti-cancer formulations, out of 1225 for which 76 companies filed revised prices, covering 121 drugs in all. About 600 brands grow cheaper by more than half and the steepest single cut reaches 96.45 per cent, which is why the aggregate saving is so large. Options A, B and D are plausible-looking amounts but none of them is the figure announced, and a candidate who remembers only the rounded headline figure of more than Rs 3500 crore should still be able to reject them. The exact number is the one worth carrying into the examination hall.

Read the full article: NPPA Caps Trade Margins on 137 Anti-Cancer Drugs

Q2.NationalMedium

Which authority has capped the trade margins on non-scheduled anti-cancer medicines?

  1. A.Central Drugs Standard Control Organisation
  2. B.National Pharmaceutical Pricing Authority
  3. C.Drug Controller General of India
  4. D.Directorate General of Health Services
Show answer
Correct answer: B. National Pharmaceutical Pricing Authority

The correct answer is the National Pharmaceutical Pricing Authority (NPPA), which works under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers and fixed the ceiling on trade margins for 137 anti-cancer drugs.